Literature DB >> 8285313

Near total laryngectomy with epiglottic reconstruction: long-term results in 57 patients.

M Zanaret1, A Giovanni, R Gras, M Cannoni.   

Abstract

INTRODUCTION: Extended partial laryngectomy procedures may offer patients the potential for a cure with preservation of voice. This report characterizes our patients managed with near laryngectomy and reconstructed with epiglottic tissue.
MATERIALS AND METHODS: A total of 57 patients with T1 or T2 glottic carcinoma undergoing total laryngectomy with epiglottic reconstruction were reviewed retrospectively. This group included 15 patients with T1 lesions and 42 patients with T2 lesions. In the standard operation the specimen includes the thyroid ala, both vocal cords, both false vocal cords, and one arytenoid cartilage. The epiglottis is mobilized and delivered inferiorly for reconstruction of the glottic larynx. RESULT: Tumor control was obtained in 93% of T1 patients and 79% of T2 patients. All patients tolerated decannulation. After a mean duration of 12 days (range 5 to 22 days), all patients were able to swallow. Voice evaluation revealed 5 patients had whispery voices, 25 were difficult to understand in a noisy environment, and 27 were easily understood. DISCUSSION: This technique is an effective approach to cancer therapy with cure rates comparable to total laryngectomy. The main limitation of this technique is that voice recovery is unpredictable.

Entities:  

Mesh:

Year:  1993        PMID: 8285313     DOI: 10.1016/0196-0709(93)90117-p

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  1 in total

1.  Analysis of swallowing after partial frontolateral laryngectomy with epiglottic reconstruction for glottic cancer.

Authors:  Nicolas Fakhry; Justin Michel; Roch Giorgi; Danielle Robert; Aude Lagier; Laure Santini; Eric Moreddu; Laurent Puymerail; Pascal Adalian; Patrick Dessi; Antoine Giovanni
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-08       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.